CarcinogenesisPub Date : 2026-11-16DOI: 10.1093/carcin/bgag073
{"title":"Retraction Notice: Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45α-dependent manner.","authors":"","doi":"10.1093/carcin/bgag073","DOIUrl":"https://doi.org/10.1093/carcin/bgag073","url":null,"abstract":"","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Targeting the NAD⁺ salvage pathway: roles of NAMPT in the tumor microenvironment.","authors":"Jinghang Wei, Shengqi Zhao, Guiquan Zhu, Wanrong Meng","doi":"10.1093/carcin/bgag083","DOIUrl":"https://doi.org/10.1093/carcin/bgag083","url":null,"abstract":"<p><p>Nicotinamide adenine dinucleotide (NAD⁺) is a central redox cofactor that supports cellular metabolism, redox balance and signal transduction. Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate-limiting step of NAD⁺ salvage pathway in both malignant and non-malignant cells of the tumor microenvironment (TME). Whilst direct restriction of NAD⁺ metabolism in cancer cells has yielded limited clinical benefit, emerging evidence reveals that NAMPT shapes antitumor immunity by reprogramming immune cell function and the metabolic landscape of the TME. Parallel advances in medicinal chemistry, including bifunctional inhibitors, drug-delivery systems and proteolysis-targeting chimeras (PROTACs) are enabling more selective NAMPT-targeted agents. This review examines the context-dependent roles of NAMPT across immune and stromal compartments of the TME and evaluates emerging therapeutic approaches, highlighting their potential to overcome current limitations and advance NAMPT-targeted immunotherapy.</p>","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Lard-Based Diet Promotes Prostate Cancer Progression through Gut microbiota-Driven Immune Suppression in the Tumor Microenvironment.","authors":"Hiromi Sato, Shintaro Narita, Yoshiko Takahashi, Shuhei Okada, Masanori Ishida, Huang Mingguo, Yuya Sekine, Mizuki Kobayashi, Soki Kashima, Ryohei Yamamoto, Kazuyuki Numakura, Mitsuru Saito, Naoshi Dohmae, Toshiaki Yoshioka, Makoto Matsushita, Kazutoshi Fujita, Norio Nonomura, Tomonori Habuchi","doi":"10.1093/carcin/bgag085","DOIUrl":"https://doi.org/10.1093/carcin/bgag085","url":null,"abstract":"<p><p>Growing epidemiological evidence indicates that dietary fats and obesity are linked to prostate cancer (PCa) progression. This study examines the impact of a lard-based diet (LD) on PCa progression through gut microbiota alterations and immune modulation. Using a prostate-specific Pten knockout mouse model, LD increased the relative abundance of the phylum Proteobacteria, which correlated with higher serum lipopolysaccharide (LPS) levels, weight gain, activation of TGF-β signaling, and accelerated PCa growth. Moreover, LD promoted Foxp3+ T cell infiltration within tumors, enhancing the immunosuppressive tumor microenvironment and driving cancer progression. Antibiotic treatment reduced both Foxp3+ T cell infiltration and serum LPS levels, highlighting the role of gut microbiota in PCa progression. Moreover, inhibiting LPS signaling suppressed high-fat diet-induced Foxp3+ T cell infiltration. In clinical samples, obesity was associated with increased FOXP3+ T cell infiltration in the prostate, while an abundance of gut class ε-Proteobacteria correlated with obesogenic phenotypes and advanced PCa features. These findings suggest that LD-induced gut microbiota changes and immune modulation contribute to PCa progression via systemic inflammation and intratumoral TGF-β signaling, presenting a potential preventive and therapeutic target for PCa.</p>","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The PDK/PDC-Lactate Axis: A Central Hub Intersecting Cancer Metabolism and Immunosuppression.","authors":"Yiyang Li, Ruilei Huang, Yuan Gao, Xuhong Zhao, Luting Zeng, Jiaqi Wang, Yi Yi, Qian Ning, Shuxian Liao, Shengsong Tang","doi":"10.1093/carcin/bgag084","DOIUrl":"https://doi.org/10.1093/carcin/bgag084","url":null,"abstract":"<p><p>Aberrant glucose metabolism is a hallmark of cancer metabolic reprogramming. The mitochondrial pyruvate dehydrogenase complex (PDC) acts as a central metabolic node that converts pyruvate into acetyl-CoA to sustain oxidative phosphorylation (OXPHOS). In tumor cells, however, overexpressed pyruvate dehydrogenase kinases (PDKs) phosphorylate and inactivate PDC, diverting carbon flux toward glycolysis and driving excessive lactate accumulation. Cumulative evidence demonstrates that microenvironmental lactate not only fuels tumor growth but also reshapes the tumor microenvironment (TME) into an immunosuppressive state that facilitates immune evasion. Conversely, pharmacological PDK inhibition effectively reverses this metabolic shift, depletes intratumoral lactate, restores mitochondrial pyruvate oxidation, and triggers tumor-selective apoptosis. Given these oncogenic and immunosuppressive functions, the PDC/PDK-lactate axis has emerged as a promising therapeutic target, prompting intensive research into the development of small-molecule PDK inhibitors. Here, we critically evaluate the evidence establishing this axis as a key driver of immune evasion. Unlike previous reviews that focused separately on metabolic or immunological aspects, this review uniquely integrates three emerging layers: (i) the isoform-selective functions of PDK1-4 in tumor metabolism and immune modulation; (ii) recently identified histone and non-histone lactylation as a direct epigenetic bridge connecting PDK activity to immune suppression; and (iii) a critical reappraisal of PDK inhibitors, with particular emphasis on the distinction between preclinical efficacy and clinical translation. Finally, we propose that isoform-selective targeting of PDK1 and PDK3, rather than pan-PDK inhibition, combined with immune checkpoint blockade, represents a promising strategy to overcome current therapeutic bottlenecks.</p>","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CarcinogenesisPub Date : 2026-11-06DOI: 10.1093/carcin/bgag082
Richard M Fleming, Matthew R Fleming
{"title":"Cancer Before Cancer: Measuring the Biological Consequences of the Modern Exposome.","authors":"Richard M Fleming, Matthew R Fleming","doi":"10.1093/carcin/bgag082","DOIUrl":"https://doi.org/10.1093/carcin/bgag082","url":null,"abstract":"<p><p>Cancer is conventionally defined when malignant transformation can be demonstrated, yet carcinogenesis is increasingly understood as a multistep biological process extending from exposure and tissue response through clonal evolution and, in some individuals, clinically apparent malignancy. The modern exposome provides a framework for considering environmental, endogenous, metabolic, infectious, occupational, and social influences that accumulate and interact across the life course. These influences can converge on chronic inflammation, oxidative stress, immune dysregulation, metabolic dysfunction, genomic instability, and epigenetic remodeling. Importantly, these processes are not specific to cancer and may accompany many chronic diseases. Their relevance to carcinogenesis therefore depends on persistence, tissue context, interaction with inherited and acquired susceptibility, and trajectories that favor clonal selection and malignant progression. This review develops a measurement-centered framework for identifying biological states that may precede clinically detectable cancer. The framework integrates quantitative assessment of tissue physiology, longitudinal biomarkers, genetic and epigenetic information, and external and internal exposure measures. It distinguishes transient physiological variation from persistent biological deviation by emphasizing magnitude, duration, reproducibility, and trajectory rather than isolated abnormal measurements. The proposed approach does not define cancer by a pre-malignant measurement or imply deterministic progression. Instead, it identifies a research pathway in which validated quantitative measurements could characterize biological states, support causal investigation, and permit longitudinal evaluation of preventive interventions before overt malignancy. Translation will require rigorous analytical and clinical validation, causal inference, longitudinal outcome studies, assessment of overdiagnosis and clinical benefit, and demonstration that measurement improves outcomes rather than merely increasing detection.</p>","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CarcinogenesisPub Date : 2026-10-30DOI: 10.1093/carcin/bgag075
{"title":"Retraction Notice: Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2.","authors":"","doi":"10.1093/carcin/bgag075","DOIUrl":"https://doi.org/10.1093/carcin/bgag075","url":null,"abstract":"","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CarcinogenesisPub Date : 2026-10-30DOI: 10.1093/carcin/bgag072
{"title":"Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.","authors":"","doi":"10.1093/carcin/bgag072","DOIUrl":"https://doi.org/10.1093/carcin/bgag072","url":null,"abstract":"","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CarcinogenesisPub Date : 2026-10-30DOI: 10.1093/carcin/bgag074
{"title":"Retraction Notice: Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.","authors":"","doi":"10.1093/carcin/bgag074","DOIUrl":"https://doi.org/10.1093/carcin/bgag074","url":null,"abstract":"","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CarcinogenesisPub Date : 2026-10-30DOI: 10.1093/carcin/bgag081
Bruno Nappo Fernandes, Eduardo Figueiredo Silva, Diego Camuzi, Sheila Coelho Soares Lima, Fernando Tadeu Trevisan Frajacomo, Luis Felipe Ribeiro Pinto
{"title":"Exercise preconditioning mitigates colon carcinogenesis through targeted epigenetic remodeling and suppression of early preneoplastic lesions.","authors":"Bruno Nappo Fernandes, Eduardo Figueiredo Silva, Diego Camuzi, Sheila Coelho Soares Lima, Fernando Tadeu Trevisan Frajacomo, Luis Felipe Ribeiro Pinto","doi":"10.1093/carcin/bgag081","DOIUrl":"https://doi.org/10.1093/carcin/bgag081","url":null,"abstract":"<p><p>Exercise reduces colorectal cancer risk, but its protective mechanisms in early carcinogenesis remain unclear. Male C57BL/6 mice (n = 10/group) were used in two experimental designs: (i) an acute molecular and epigenetic study to evaluate early changes 8h and 24h after a single Azoxymethane (AOM) dose; and (ii) a chronic carcinogenic model to assess the biological efficacy of exercise timing on premalignant lesions (Aberrant and mucin-depleted foci) after 6 weeks of AOM exposure. In both, mice underwent a 6-week progressive swimming protocol initiated either before (preconditioning) or concurrent with AOM. We demonstrate that 6-week exercise preconditioning, rather than concurrent training, conferred protection against mucin-depleted foci incidence (P = 0.03). Mechanistically, exercise preconditioning remodeled colon tissue to resist genotoxic stress, evidenced by an accelerated normalization of DNA repair kinetics (Mgmt expression returned to baseline by 24h vs sustained elevation in the AOM non-exercised group, P = 0.002). Exercise preconditioning also induced colon-specific epigenetic reprogramming, including Mgmt promoter hypermethylation (27% increase, P = 0.0043) and 3-fold reduction in expression of the mutagenic deaminase Apobec3 (P < 0.0001). These molecular changes occurred without altering global LINE-1 methylation or body composition, suggesting targeted tissue adaptation rather than systemic effects. These results demonstrate that exercise preconditioning, not concurrent training, provides colon preneoplastic prevention by enhancing DNA repair efficiency and suppressing Apobec3, a key driver of genomic instability and chronic mutational signatures, during the critical window of carcinogen attack.</p>","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}